The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world evidence on predictors of survival for hormone-positive and triple-negative advanced breast cancer by treatment and BRCA status in the United States.
 
Dongmu Zhang
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Leon Raskin
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Wendy Sebby
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Lei He
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Patents, Royalties, Other Intellectual Property - 1. Genomic signature predicting veliparib sensitivity in lung cancer patients (U.S. Application No. 62/524,711) 2. Tubulin mutations predict response to Depatuxizumab Mafodotin in patients with Glioblastoma (U.S. Application No. 16/195,384)
 
Sandeep Pawar
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Steven A Narod
No Relationships to Disclose
 
Olufunmilayo I. Olopade
Employment - CancerIQ (I)
Leadership - CancerIQ
Stock and Other Ownership Interests - 54gene; CancerIQ; HealthWell Solutions; Tempus
Research Funding - Ayala Pharmaceuticals (Inst); Cepheid (Inst); Color Genomics (Inst); Novartis (Inst); Roche/Genentech (Inst)
Other Relationship - Color Genomics; Roche/Genentech; Tempus
(OPTIONAL) Uncompensated Relationships - Healthy Life for All Foundation
 
Alexander Liede
Employment - AbbVie; Gilead Sciences (I)
Stock and Other Ownership Interests - Abbvie; Gilead Sciences (I)